Moreover, transforming growth factor-β1 (TGF-β1) overexpression facilitated MSCs homing to ischemia-reperfusion injury renal tissue by upregulating expression of CXCR4 mRNA on cell membranes, thereby enhancing the therapeutic effects of MSCs in AKI treatment [23]. This evidence concerns the gene CXCR4 and acute kidney injury.